"I've never seen anything bigger"
According to one Wall Street Legend, "for those who take early action, it could make 2021 one of your best years ever".
Watch more here!

CRSP Insider Trading (CRISPR Therapeutics)

Insider Ownership Percentage: 17.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $102,194,551.29

CRISPR Therapeutics Insider Trading History Chart

CRISPR Therapeutics Share Price & Price History

$129.20
▲ +1.37 (1.07%)
As of 06/21/2021 04:40 PM ET
Days: 30 | 90 | 365
[URGENT] MAJOR BUY ALERT
Since 2016, Teeka Tiwari has trumped the stock market. His investment recommendations have each averaged 281%. That’s 17 times the S&P. And 112 times the average investor, according to JPMorgan!

However, one investment Teeka just uncovered could top them all… It involves former President Biden, billions of dollars, several large banks, and a super-rich family. As well as a MAJOR potential upgrade to our credit cards.

Teeka, who ended up correctly picking the last “investment of the decade,” is declaring this his top pick for the 2020s.
See Teeka's Top Pick...

CRISPR Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/15/2021Samarth KulkarniCEOSell30,000$126.43$3,792,900.00217,719View SEC Filing Icon  
6/11/2021Bradley J Phd BolzonDirectorSell10,000$126.61$1,266,100.0024,948View SEC Filing Icon  
3/22/2021Bradley J Phd BolzonDirectorSell30,374$132.37$4,020,606.3857,149View SEC Filing Icon  
1/19/2021James R. KasingerGeneral CounselSell27,500$204.94$5,635,850.00View SEC Filing Icon  
1/15/2021Lawrence Otto KleinCOOSell25,000$215.20$5,380,000.0028,666View SEC Filing Icon  
1/15/2021Samarth KulkarniCEOSell20,000$213.67$4,273,400.00202,989View SEC Filing Icon  
12/21/2020Tony W. HoVPSell23,551$149.23$3,514,515.73View SEC Filing Icon  
12/16/2020Bradley J Phd BolzonDirectorSell7,648$148.95$1,139,169.606,734View SEC Filing Icon  
12/10/2020Bradley J Phd BolzonDirectorSell33,000$143.35$4,730,550.0040,648View SEC Filing Icon  
12/10/2020Samarth KulkarniCEOSell20,000$142.29$2,845,800.00189,189View SEC Filing Icon  
12/7/2020Bradley J Phd BolzonDirectorSell171,004$154.53$26,425,248.1240,648View SEC Filing Icon  
11/30/2020Rodger NovakPresidentSell100,000$125.00$12,500,000.00698,007View SEC Filing Icon  
9/18/2020Bradley J Phd BolzonDirectorSell3,035$86.87$263,650.457,391View SEC Filing Icon  
9/16/2020Bradley J Phd BolzonDirectorSell8,965$86.98$779,775.707,391View SEC Filing Icon  
9/14/2020Bradley J Phd BolzonDirectorSell1,155$84.89$98,047.957,391View SEC Filing Icon  
9/10/2020Bradley J Phd BolzonDirectorSell22,845$85.36$1,950,049.207,391View SEC Filing Icon  
9/1/2020Bradley J Phd BolzonDirectorSell60,000$92.51$5,550,600.00View SEC Filing Icon  
9/1/2020Michael John TomsicekCFOSell12,000$92.26$1,107,120.0012,410View SEC Filing Icon  
9/1/2020Rodger NovakPresidentSell25,000$92.62$2,315,500.00651,940View SEC Filing Icon  
7/7/2020Rodger NovakPresidentSell25,000$90.00$2,250,000.00653,593View SEC Filing Icon  
7/6/2020Bradley J Phd BolzonDirectorSell20,000$82.39$1,647,800.00View SEC Filing Icon  
6/24/2020Lawrence Otto KleinCOOSell65,088$75.93$4,942,131.8458,666View SEC Filing Icon  
6/23/2020Bradley J Phd BolzonDirectorSell20,000$73.93$1,478,600.00View SEC Filing Icon  
6/23/2020Rodger NovakPresidentSell50,000$75.00$3,750,000.00698,007View SEC Filing Icon  
6/23/2020Tony W HoVPSell7,158$75.04$537,136.3240,676View SEC Filing Icon  
6/1/2020Samarth KulkarniCEOSell17,275$64.68$1,117,347.00188,801View SEC Filing Icon  
5/20/2020Samarth KulkarniCEOSell10,693$65.28$698,039.04175,833View SEC Filing Icon  
5/19/2020Rodger NovakPresidentSell50,000$65.00$3,250,000.00798,007View SEC Filing Icon  
5/11/2020Lawrence Otto KleinCOOSell25,000$60.40$1,510,000.0045,000View SEC Filing Icon  
11/19/2019Pablo J CagnoniDirectorSell7,500$62.00$465,000.007,500View SEC Filing Icon  
11/19/2019Rodger NovakPresidentSell33,618$70.00$2,353,260.0033,618View SEC Filing Icon  
11/12/2019Pablo J CagnoniDirectorSell7,500$55.00$412,500.007,500View SEC Filing Icon  
10/30/2019Pablo J CagnoniDirectorSell7,500$52.00$390,000.007,500View SEC Filing Icon  
7/11/2019Lawrence Otto KleinInsiderSell20,000$50.02$1,000,400.0031,579View SEC Filing Icon  
7/10/2019Rodger NovakPresidentSell50,000$50.00$2,500,000.00848,007View SEC Filing Icon  
6/17/2019Samarth KulkarniCEOSell20,000$46.00$920,000.00185,801View SEC Filing Icon  
6/10/2019Rodger NovakPresidentSell50,000$45.00$2,250,000.00898,007View SEC Filing Icon  
4/29/2019Samarth KulkarniCEOSell20,000$42.03$840,600.00186,542View SEC Filing Icon  
3/4/2019Rodger NovakPresidentSell85,220$40.40$3,442,888.001,024,534View SEC Filing Icon  
3/1/2019Rodger NovakPresidentSell8,693$40.01$347,806.931,024,534View SEC Filing Icon  
2/25/2019Rodger NovakPresidentSell14,780$40.00$591,200.001,033,227View SEC Filing Icon  
1/8/2019Rodger NovakPresidentSell17,310$35.09$607,407.901,130,697View SEC Filing Icon  
12/27/2018Vertex Pharmaceuticals (EuropeMajor ShareholderBuy40,198$24.93$1,002,136.14View SEC Filing Icon  
12/24/2018Vertex Pharmaceuticals (EuropeMajor ShareholderBuy90,742$24.08$2,185,067.36View SEC Filing Icon  
12/21/2018Vertex Pharmaceuticals (EuropeMajor ShareholderBuy22,742$22.58$513,514.36View SEC Filing Icon  
12/18/2018Kurt Von EmsterDirectorSell72,934$29.85$2,177,079.90View SEC Filing Icon  
7/5/2018Pablo J CagnoniDirectorSell7,500$62.00$465,000.005,816View SEC Filing Icon  
7/3/2018Pablo J CagnoniDirectorSell5,816$62.00$360,592.005,816View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for CRISPR Therapeutics (NASDAQ:CRSP)

55.60% of CRISPR Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

CRISPR Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/16/2021Nia Impact Advisors LLC37,892$4.62M2.5%+13.2%0.050%Search for SEC Filing on Google Icon
6/5/2021Advisory Services Network LLC10,158$1.24M0.0%+22.2%0.013%Search for SEC Filing on Google Icon
5/25/2021Capital Advisors Inc. OK67,757$8.26M0.3%-22.7%0.089%Search for SEC Filing on Google Icon
5/24/2021Garde Capital Inc.849$0.10M0.0%N/A0.001%Search for SEC Filing on Google Icon
5/24/2021Principal Financial Group Inc.15,754$1.92M0.0%N/A0.021%Search for SEC Filing on Google Icon
5/21/2021Colony Group LLC2,000$0.24M0.0%N/A0.003%Search for SEC Filing on Google Icon
5/20/2021Slow Capital Inc.16,387$2.37M0.5%+0.5%0.022%Search for SEC Filing on Google Icon
5/20/2021Axiom Investment Management LLC2,826$0.34M0.1%N/A0.004%Search for SEC Filing on Google Icon
5/19/2021Draper Asset Management LLC3,697$0.45M0.5%+110.1%0.005%Search for SEC Filing on Google Icon
5/19/2021Gladstone Institutional Advisory LLC2,653$0.32M0.1%N/A0.004%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC21,000$2.56M0.2%N/A0.028%Search for SEC Filing on Google Icon
5/19/2021Twin Lakes Capital Management LLC428$52K0.0%N/A0.001%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC11,852$1.44M0.0%+134.5%0.016%Search for SEC Filing on Google Icon
5/18/2021Canada Pension Plan Investment Board25,623$3.12M0.0%N/A0.034%Search for SEC Filing on Google Icon
5/18/2021Utah Retirement Systems8,600$1.05M0.0%N/A0.011%Search for SEC Filing on Google Icon
5/18/2021Voloridge Investment Management LLC41,259$5.03M0.0%+41.3%0.054%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley867,268$105.68M0.0%+18.6%1.145%Search for SEC Filing on Google Icon
5/18/2021Orbimed Advisors LLC552,500$67.32M0.6%+22.3%0.729%Search for SEC Filing on Google Icon
5/18/2021Perigon Wealth Management LLC6,438$0.78M0.1%+14.8%0.008%Search for SEC Filing on Google Icon
5/18/2021Cubist Systematic Strategies LLC4,060$0.50M0.0%-91.6%0.005%Search for SEC Filing on Google Icon
5/18/2021IHT Wealth Management LLC8,600$1.05M0.1%-8.7%0.011%Search for SEC Filing on Google Icon
5/18/2021Steel Peak Wealth Management LLC2,611$0.32M0.0%N/A0.003%Search for SEC Filing on Google Icon
5/18/2021FORA Capital LLC1,986$0.24M0.1%-87.2%0.003%Search for SEC Filing on Google Icon
5/18/2021Man Group plc1,814$0.22M0.0%-92.7%0.002%Search for SEC Filing on Google Icon
5/18/2021Valiant Capital Management L.P.307,700$37.49M1.5%-13.4%0.406%Search for SEC Filing on Google Icon
5/18/2021Ameritas Investment Company LLC242$29K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/17/2021JS Capital Management LLC2,600$0.32M0.0%N/A0.003%Search for SEC Filing on Google Icon
5/17/2021Eudaimonia Partners LLC254$31K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada229,588$27.98M0.0%+3.4%0.303%Search for SEC Filing on Google Icon
5/17/2021Armistice Capital LLC156,000$19.01M0.4%+116.7%0.206%Search for SEC Filing on Google Icon
5/17/2021Edmond DE Rothschild Holding S.A.6,206$0.76M0.0%+380.3%0.008%Search for SEC Filing on Google Icon
5/17/2021Price T Rowe Associates Inc. MD1,298,329$158.20M0.0%-26.8%1.714%Search for SEC Filing on Google Icon
5/17/2021Captrust Financial Advisors22,050$2.69M0.0%+27.8%0.029%Search for SEC Filing on Google Icon
5/17/2021Intellectus Partners LLC10,170$1.24M0.3%+13.4%0.013%Search for SEC Filing on Google Icon
5/17/2021Ameriprise Financial Inc.466,292$56.82M0.0%+3.9%0.615%Search for SEC Filing on Google Icon
5/17/2021HRT Financial LP10,509$1.28M0.0%N/A0.014%Search for SEC Filing on Google Icon
5/17/2021Thrivent Financial for Lutherans2,583$0.32M0.0%+60.3%0.003%Search for SEC Filing on Google Icon
5/14/2021Brown Advisory Inc.4,079$0.50M0.0%+35.0%0.005%Search for SEC Filing on Google Icon
5/14/2021Thomas J. Herzfeld Advisors Inc.417$51K0.0%+2,352.9%0.001%Search for SEC Filing on Google Icon
5/14/2021MML Investors Services LLC4,016$0.49M0.0%-4.1%0.005%Search for SEC Filing on Google Icon
5/14/2021Brevan Howard Capital Management LP14,911$1.82M0.3%-35.7%0.020%Search for SEC Filing on Google Icon
5/14/2021Professional Planning3,995$0.49M0.2%+7.7%0.005%Search for SEC Filing on Google Icon
5/14/2021Capital International Investors4,868,689$593.19M0.2%-34.4%6.426%Search for SEC Filing on Google Icon
5/14/2021Eqis Capital Management Inc.23,009$2.80M0.2%N/A0.030%Search for SEC Filing on Google Icon
5/14/2021CloudAlpha Capital Management Limited Hong Kong52,000$6.34M0.2%+1,633.3%0.069%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP138,750$16.90M0.0%+28.9%0.183%Search for SEC Filing on Google Icon
5/14/2021Tekla Capital Management LLC150,958$18.39M0.6%+98.1%0.199%Search for SEC Filing on Google Icon
5/14/2021Montag A & Associates Inc.4,092$0.50M0.0%-4.9%0.005%Search for SEC Filing on Google Icon
5/14/2021Moneta Group Investment Advisors LLC3,545$0.43M0.0%N/A0.005%Search for SEC Filing on Google Icon
5/14/2021TD Asset Management Inc.31,396$3.83M0.0%-1.0%0.041%Search for SEC Filing on Google Icon
5/14/2021UBS Asset Management Americas Inc.141,054$17.19M0.0%+32.1%0.186%Search for SEC Filing on Google Icon
5/14/2021Rikoon Group LLC3,812$0.46M0.1%+10.6%0.005%Search for SEC Filing on Google Icon
5/14/2021Stifel Financial Corp22,490$2.74M0.0%+33.9%0.030%Search for SEC Filing on Google Icon
5/14/2021Sectoral Asset Management Inc3,270$0.40M0.0%-86.9%0.004%Search for SEC Filing on Google Icon
5/14/2021HBK Sorce Advisory LLC1,677$0.20M0.0%N/A0.002%Search for SEC Filing on Google Icon
5/13/2021Guggenheim Capital LLC31,370$3.82M0.0%+66.6%0.041%Search for SEC Filing on Google Icon
5/13/2021Franklin Resources Inc.829,354$101.06M0.0%+0.5%1.095%Search for SEC Filing on Google Icon
5/13/2021Trexquant Investment LP10,855$1.32M0.1%N/A0.014%Search for SEC Filing on Google Icon
5/13/2021Axiom Investment Management LLC8,726$1.06M0.2%N/A0.012%Search for SEC Filing on Google Icon
5/13/2021SG Americas Securities LLC59,710$7.28M0.0%+1,013.2%0.079%Search for SEC Filing on Google Icon
5/13/2021ARK Investment Management LLC8,290,350$1.01B2.0%-20.4%10.942%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC5,800$0.71M0.0%-70.6%0.008%Search for SEC Filing on Google Icon
5/13/2021RMR Wealth Builders237$29K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC123,110$15M0.0%-19.6%0.162%Search for SEC Filing on Google Icon
5/13/2021Sawtooth Solutions LLC4,219$0.51M0.1%N/A0.006%Search for SEC Filing on Google Icon
5/13/2021Duality Advisers LP4,303$0.52M0.0%N/A0.006%Search for SEC Filing on Google Icon
5/13/2021Bpifrance SA8,000$0.98M0.0%N/A0.011%Search for SEC Filing on Google Icon
5/13/2021Neuberger Berman Group LLC3,240$0.40M0.0%+25.0%0.004%Search for SEC Filing on Google Icon
5/13/2021IMA Wealth Inc.26,263$3.20M0.8%+14.6%0.035%Search for SEC Filing on Google Icon
5/13/2021Avitas Wealth Management LLC16,350$1.99M0.4%-21.7%0.022%Search for SEC Filing on Google Icon
5/13/2021Avantax Advisory Services Inc.2,139$0.26M0.0%N/A0.003%Search for SEC Filing on Google Icon
5/13/2021Manchester Capital Management LLC800$97K0.0%-13.4%0.001%Search for SEC Filing on Google Icon
5/13/2021Sand Hill Global Advisors LLC4,898$0.60M0.0%N/A0.006%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp44,937$5.48M0.0%+12.8%0.059%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.26,026$3.17M0.0%-17.3%0.034%Search for SEC Filing on Google Icon
5/13/2021WS Management Lllp18,876$2.30M0.2%-4.9%0.025%Search for SEC Filing on Google Icon
5/13/2021Van ECK Associates Corp119,081$14.51M0.0%N/A0.157%Search for SEC Filing on Google Icon
5/13/2021Blair William & Co. IL80,472$9.81M0.0%+13.6%0.106%Search for SEC Filing on Google Icon
5/13/2021Federated Hermes Inc.586,818$71.50M0.1%-7.9%0.774%Search for SEC Filing on Google Icon
5/13/2021Mirae Asset Global Investments Co. Ltd.71,482$8.71M0.0%+81.1%0.094%Search for SEC Filing on Google Icon
5/13/2021Bank of Montreal Can1,422$0.17M0.0%-36.5%0.002%Search for SEC Filing on Google Icon
5/13/2021Baird Financial Group Inc.3,072$0.37M0.0%+54.2%0.004%Search for SEC Filing on Google Icon
5/13/2021Concord Wealth Partners575$70K0.0%N/A0.001%Search for SEC Filing on Google Icon
5/13/2021CKW Financial Group338$41K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/13/2021Allianz Asset Management GmbH25,827$3.15M0.0%+17.1%0.034%Search for SEC Filing on Google Icon
5/13/2021Altshuler Shaham Ltd1,000$0.12M0.0%N/A0.001%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp59,875$7.30M0.0%+25.0%0.079%Search for SEC Filing on Google Icon
5/12/2021Ergoteles LLC126,111$15.37M0.5%N/A0.166%Search for SEC Filing on Google Icon
5/12/2021Cerity Partners LLC2,520$0.31M0.0%N/A0.003%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC64,036$7.80M0.0%+22.0%0.085%Search for SEC Filing on Google Icon
5/12/2021Cresset Asset Management LLC17,603$2.15M0.0%+44.5%0.023%Search for SEC Filing on Google Icon
5/12/2021Bluestein R H & Co.7,450$0.91M0.0%+13.7%0.010%Search for SEC Filing on Google Icon
5/12/2021Waddell & Reed Financial Inc.1,071,487$130.56M0.3%-11.7%1.414%Search for SEC Filing on Google Icon
5/12/2021Essex Investment Management Co. LLC35,540$4.33M0.5%N/A0.047%Search for SEC Filing on Google Icon
5/12/2021Sloy Dahl & Holst LLC27,163$3.31M0.5%N/A0.036%Search for SEC Filing on Google Icon
5/12/2021Y Intercept Hong Kong Ltd7,448$0.86M0.2%N/A0.010%Search for SEC Filing on Google Icon
5/12/2021Advisors Capital Management LLC21,556$2.63M0.1%N/A0.028%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.550,410$67.07M0.0%+21.9%0.726%Search for SEC Filing on Google Icon
5/12/2021CIBC Private Wealth Group LLC30,805$3.75M0.0%+407.5%0.041%Search for SEC Filing on Google Icon
5/12/2021Sei Investments Co.2,357$0.29M0.0%+12.2%0.003%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
CRISPR Therapeutics logo
CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases. The company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), a gene editing technology that allows for precise directed changes to genomic DNA. It has a portfolio of therapeutic programs in a range of disease areas, including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company's lead product candidate is CTX001, an ex vivo CRISPR gene-edited therapy for treating patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. It is also developing CTX110, a donor-derived gene-edited allogeneic CAR-T therapy targeting cluster of differentiation 19 positive malignancies. In addition, the company is developing allogeneic CAR-T programs comprising CTX120 targeting B-cell maturation antigen for the treatment of relapsed or refractory multiple myeloma; and CTX130 for the treatment of solid tumors and hematologic malignancies. Further, it engages in the development of regenerative medicine programs in diabetes; and in vivo and other genetic disease programs to treat glycogen storage disease Ia, Duchenne muscular dystrophy, myotonic dystrophy type 1, and cystic fibrosis. The company has strategic partnerships with Bayer Healthcare LLC, Vertex Pharmaceuticals Incorporated, and ViaCyte, Inc. It also has a strategic partnership with Nkarta, Inc. to research, develop, and commercialize CRISPR/Cas9 gene-edited cell therapies for cancer. The company was formerly known as Inception Genomics AG and changed its name to CRISPR Therapeutics AG in April 2014. CRISPR Therapeutics AG was incorporated in 2013 and is headquartered in Zug, Switzerland.
Read More on CRISPR Therapeutics

Today's Range

Now: $129.20
$124.90
$130.44

50 Day Range

MA: $118.62
$100.84
$135.72

52 Week Range

Now: $129.20
$68.01
$220.20

Volume

45,181 shs

Average Volume

1,840,631 shs

Market Capitalization

$9.79 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.26

Who are the company insiders with the largest holdings of CRISPR Therapeutics?

CRISPR Therapeutics' top insider shareholders include:
  1. Rodger Novak (President)
  2. Samarth Kulkarni (CEO)
  3. Lawrence Otto Klein (COO)
  4. Bradley J Phd Bolzon (Director)
  5. Tony W Ho (VP)
  6. Lawrence Otto Klein (Insider)
  7. Michael John Tomsicek (CFO)
  8. Pablo J Cagnoni (Director)
  9. James R Kasinger (General Counsel)
  10. Tony W Ho (VP)

Who are the major institutional investors of CRISPR Therapeutics?

CRISPR Therapeutics' top institutional shareholders include:
  1. ARK Investment Management LLC — 10.94%
  2. Capital International Investors — 6.43%
  3. Nikko Asset Management Americas Inc. — 4.83%
  4. Versant Venture Management LLC — 2.05%
  5. Price T Rowe Associates Inc. MD — 1.71%
  6. BlackRock Inc. — 1.70%

Which institutional investors are selling CRISPR Therapeutics stock?

During the previous quarter, CRSP stock was sold by these institutional investors:
  1. Capital International Investors
  2. ARK Investment Management LLC
  3. Versant Venture Management LLC
  4. Price T Rowe Associates Inc. MD
  5. Nikko Asset Management Americas Inc.
  6. Waddell & Reed Financial Inc.
  7. Federated Hermes Inc.
  8. Valiant Capital Management L.P.
In the last year, company insiders that have sold CRISPR Therapeutics company stock include:
  1. Rodger Novak (President)
  2. Samarth Kulkarni (CEO)
  3. Lawrence Otto Klein (COO)
  4. Bradley J Phd Bolzon (Director)
  5. Tony W Ho (VP)
  6. Lawrence Otto Klein (Insider)
  7. Michael John Tomsicek (CFO)
  8. Pablo J Cagnoni (Director)

Which institutional investors are buying CRISPR Therapeutics stock?

During the previous quarter, CRSP stock was acquired by institutional investors including:
  1. Morgan Stanley
  2. Ergoteles LLC
  3. Van ECK Associates Corp
  4. BlackRock Inc.
  5. UBS Group AG
  6. Orbimed Advisors LLC
  7. JPMorgan Chase & Co.
  8. Armistice Capital LLC
"I've never seen anything bigger"
According to one Wall Street Legend, "for those who take early action, it could make 2021 one of your best years ever".
Watch more here!